Inactive Instrument
Pressure BioSciences, Inc. Share Price Other OTC
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 143K 126K 116K 108K 203K 13.53M 208K 1.39M 539K 6.68M 538K 527K 23.18M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.12M 18.55M 17.36M 32.56M 2.16B 33.24M 223M 86.26M 1.07B 86.17M 84.29M 3.71B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 15/04/2004 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 23/04/2006 |
| Chief Tech/Sci/R&D Officer | 61 | 02/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 31/12/1991 | |
Jeffrey Peterson
CHM | Chairman | 70 | 07/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 07/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 30.08K | |
| +1.44% | +10.42% | +24.49% | -1.72% | 191B | |
| +1.25% | -0.51% | -24.24% | +24.46% | 143B | |
| +1.75% | +10.74% | -2.62% | -17.53% | 139B | |
| +0.07% | -2.34% | -57.71% | -17.33% | 65.74B | |
| +1.18% | +3.91% | +17.67% | +1.44% | 52.27B | |
| -0.52% | -0.03% | -26.94% | -32.29% | 43.55B | |
| +0.37% | +7.04% | +13.89% | +14.90% | 38.41B | |
| -0.66% | +5.34% | +5.49% | +44.15% | 36.76B | |
| +1.26% | +6.77% | -12.16% | -15.48% | 29.91B | |
| Average | +0.61% | +4.45% | -6.90% | +0.07% | 82.17B | |
| Weighted average by Cap. | +1.04% | +5.19% | -3.84% | +0.01% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.52M 1.4M 1.31M 2.45M 163M 2.5M 16.8M 6.5M 80.62M 6.49M 6.35M 280M | 1.98M 1.73M 1.6M 1.5M 2.81M 187M 2.86M 19.21M 7.43M 92.21M 7.43M 7.26M 320M |
| Net income | -16.08M -14.1M -12.99M -12.16M -22.81M -1.52B -23.28M -156M -60.43M -750M -60.37M -59.05M -2.6B | -29.31M -25.7M -23.69M -22.18M -41.59M -2.77B -42.46M -285M -110M -1.37B -110M -108M -4.74B |
| Net Debt | 20.53M 18M 16.59M 15.53M 29.12M 1.94B 29.73M 199M 77.15M 957M 77.07M 75.39M 3.32B | 22.8M 20M 18.43M 17.26M 32.36M 2.15B 33.03M 222M 85.72M 1.06B 85.63M 83.76M 3.69B |
Employees
-
